Jonathan S Rosenblum Selected Research

AX 7503

1/2007

Polo-like kinases inhibited by wortmannin. Labeling site and downstream effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan S Rosenblum Research Topics

Disease

6	Neoplasms (Cancer) 01/2017 - 03/2004
1	Breast Neoplasms (Breast Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

2	Casein Kinases (Casein Kinase)IBA 01/2017 - 01/2016
1	Adenosine Triphosphate (ATP)IBA 01/2016
1	Aspartic Acid (Aspartate)FDA Link 01/2016
1	Cyclin-Dependent Kinase 4IBA 01/2016
1	human ERBB2 proteinIBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Phosphates (Orthophosphate)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	Estrogen ReceptorsIBA 01/2016
1	Retinoblastoma ProteinIBA 01/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2016
1	palbociclibIBA 01/2016
1	Serine (L-Serine)FDA Link 09/2012
1	HydrolasesIBA 09/2012
1	Proteins (Proteins, Gene)FDA Link 09/2012
1	AX 7503IBA 01/2007
1	Polo-like KinasesIBA 01/2007
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 03/2004

Therapy/Procedure

1	Therapeutics 09/2012